Ayurvedic management for Mootra krichra (Urinary Tract Infection)

A comparative clinical study to evaluate the bactericidal effect of amalaki vati and ciprofloxacin in the management of mootrakrichra (UTI)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/031806

Enrollment

Registered

2021-03-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Amalaki Vati: Amalaki vati 500mg BD orally for 7 days Control Intervention1: tab ciprofloxacin 500mg: Tab ciprofloxacin 500mg BD for 7 days

Eligibility

Inclusion criteria

Inclusion criteria: a. Patients showing symptoms like Pain and Burning Micturition of either sex. b. Patients aged between 25 years to 45 years. c. Micro-organisms present in Urine Culture

Exclusion criteria

Exclusion criteria: a. Women during menstrual period. b. Patients suffering from STDs. c. Patient suffering from AKD/CKD d. Any other systemic disorders like Uncontrolled DM, HTN and systemic diseases like TB, Cardiac pathology, HbsAgetc

Design outcomes

Primary

Measure	Time frame
reduce pain and burning micturationTimepoint: 7 days	—

Secondary

Measure	Time frame
reduced pain and burning micturation and improved patients lifestyleTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Aakash Kembhavi

Shree jagadguru gavisidheshwara medical college koppal

drkembhavikpl@gmail.com9886759499

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026